COMPENSATION: Competitive with share options available
LOCATION: The Schrodinger Building, Oxford Science Park, Oxford
HOURS: Full-time
CONTRACT TYPE: Permanent
COMPENSATION: Competitive with share options available
LOCATION: The Schrodinger Building, Oxford Science Park, Oxford
HOURS: Full-time
CONTRACT TYPE: Permanent
NUCLEOME THERAPEUTICS, a fast-growing biopharma that is building a passionate, creative, and dedicated multi-disciplinary team of scientists with expertise in gene regulation, genomics, machine learning, drug discovery, data analysis and software development, whose mission is to decode and mine the regulatory “dark matter” of the human genome to transform drug target discovery and deliver first-in-class precision medicine for autoimmune diseases. We are building a rewarding and fun environment where people embrace creative ways of thinking, take smart risks, and feel empowered to make a difference.
The drug discovery team are looking for a talented scientist with a background in cellular pharmacology in primary immune cells to support the progression into the pipeline of the early biologics drug targets emerging from Nucleome’s proprietary platform technology. In this lab-based role you will develop primary and secondary assays for evaluation of early biologics drug molecules, engage in mechanism of action studies and support the progression of multiple asset programmes in early drug discovery. You will develop assays to test therapeutic hypotheses, investigate the pharmacology of tool and candidate molecules, and characterise the biological impact of drug molecules in ‘on target’ and ‘off target’ cell types. You will work with a team of experienced drug discovery scientists and have the opportunity to broaden your expertise and understanding of drug discovery. In your position you will work in close collaboration with other scientists across cross-functional teams and will have responsibility for delivery of defined studies. You will achieve visibility for your work by frequent presentation across team meetings and collaborative interactions.
At Nucleome Therapeutics equality, diversity and inclusion is really important to us. We welcome applications from all candidates irrespective of age, disability, gender, gender identity, sexual orientation, race, religion or belief, or marital or civil partnership status.